– Liste non exhaustive –

2019

2019.05 – Myalgia and chronic fatigue syndrome following immunization : macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system – Romain K. Gherardia, Guillemette Crépeaux, François-Jérome Authier

2019.08 – Aluminium in human brain tissue: how much is too much? – Christopher Exley · Matthew J. Mold

De 2015 à 2018

2018.10 – Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only – Javier Asin, Maria Pascual-Alonso, Pedro Pinczowski, Marina Gimeno, Marta Perez, Ana Muniesa, Lorena de Pablo, Ignacio de Blas, Delia Lacasta, Antonio Fernandez, Damian de Andres, Gustavo Marıa, Ramses Reina, Lluıs Lujan

2018.10 – Granulomas Following Subcutaneous Injection With Aluminum Adjuvant-Containing Products in Sheep – Javier Asın, Jessica Molın, Marta Perez, Pedro Pinczowski, Marina Gimeno, Nuria Navascues, Ana Muniesa, Ignacio de Blas, Delia Lacasta, Antonio Fernandez, Lorena de Pablo, Matthew Mold , Christopher Exley, Damian de Andres, Ramses Reina, and Lluıs Lujan

2018.10 – Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing – Endika Varela-Martínez, Naiara Abendaño, Javier Asín, Maialen Sistiaga-Poveda, Marta Maria Pérez, Ramsés Reina, Damián de Andrés, Lluís Luján and Begoña M. Jugo

2018.08 – Aluminium in Brain Tissue in Multiple Sclerosis – M. Mold, A. Chmielecka, M. R. Ramirez Rodriguez, F. Thom, C. Linhart, A. King, C. Exley

2017.12 – Aluminium in brain tissue in autisme – M. Mold, D. Umar, A. King, C. Exley

2017.07 – Adjuvants aluminiques des vaccins : analyse critique des études toxicocinétiques de référence

2017.01 – Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity – Crépeaux G & al. in Toxicology

2016.11 – Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin – Aratani S & al. in Nature – Scientific reports

2016.10 – Brain FDG-PET metabolic abnormalities in patients with long-lasting macrophagic myofasciitis – Van Der Gucht A & al. in J Nucl Med

2016.10 – Calcium phosphate: a substitute for aluminum adjuvants? – Masson JD & al. in Expert Rev Vaccines

2016.08 – Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations – Mold M & al. in Nature – Scientific reports

2016.07 – Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil – Inbar R & al. in Immunol Res.

2016.06 – Sujet périphérique (aluminium et antiperspirant) – Aluminium and the human breast – Darbre PD in Morphologie.

2016.06 – Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease – Gherardi RK & al. in Morphologie

2015.11 – Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections – Crépeaux G & al. in J Inorg Biochem

2015.11 – Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line – Ligi D & al. in J Inorg Biochem

2015.10 – Vaccines, adjuvants and autoimmunity – Guimarães LE & al. in Pharmacol Res

2015.08 – A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis – Gruber N & al. in Curr Opin Obstet Gynecol

2015.07 – Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections. –Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J – J Inorg Biochem.

2015.06 – Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis – Axel Van Der Gucht, Mehdi Aoun Sebaiti, Emmanuel Itti, Jessie Aouizerate, Eva Evangelista, Julia Chalaye, Romain K. Gherardi, Nilusha Ragunathan-Thangarajah, Anne-Catherine Bachoud-Levi, François-Jérôme Authier.

2015.05 – Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition – Eidi H & al. in BMC Med.2015.11 – Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line – Ligi D & al. in J Inorg Biochem

2015.01 – Exposure to mercury and aluminum in early life: developmental vulnerability as a modifying factor in neurologic and – immunologic effects. – Dórea JG. Int J Environ Res Public Health.

2015 – Biopersistence and brain translocation of aluminum adjuvants of vaccines – Romain Kroum Gherardi, Housam Eidi, Guillemette Crépeaux, François Jerome Authier and Josette Cadusseau – Frontiers in Neurology doi: 10.3389/fneur.2015.00004.

De 2011 à 2014

2014 – Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA – Josette Cadusseau, Nilusha Ragunathan-Thangarajah, Mathieu Surenaud, Sophie Hue, François-Jérôme Authier, et Romain K. Gherardi.

2014 – Macrophagic myofasciitis and vaccination: Consequence or coincidence? – T. Santiago · O. Rebelo · L. Negrão · A. Matos – Rheumatol Int – DOI 10.1007/s00296-014-3065-4.

2014 – Etiology of autism spectrum disorders: Genes, environment, or both ? – C. A. Shaw, S. Sheth, D. Li, L. Tomljenovic – OA Autism 2014 Jun 10;2(2):11.

2014 – Why industry propaganda and political interference cannot disguise the inevitable role played by human exposure to aluminum in neurodegenerative diseases, including Alzheimer’s disease – Christopher Exley – Front. Neurol. 5:212. doi: 10.3389/fneur.2014.00212.

2014 – Aluminum-Induced Entropy in Biological Systems: Implications for Neurological Disease – Christopher A. Shaw, Stephanie Seneff, Stephen D. Kette, Lucija Tomljenovic, JohnW. Oller Jr., and RobertM. Davidson.

2014 – Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? – Christopher A Shaw, Dan Li & Lucija Tomljenovic- Immunotherapy 2014;6(10):1055-71. doi: 10.2217/imt.14.81.

2014 – Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination – Dominique Le Houezec – Immunol Res DOI 10.1007/s12026-014-8574-4.

2014 – Clinical features in patients with long-lasting macrophagic myofasciitis – Muriel Rigolet, Jessie Aouizerate, Maryline Couette, Nilusha Ragunathan-Thangarajah, Mehdi Aoun-Sebaiti, Romain Kroum Gherardi, Josette Cadusseau and François Jérôme Authier  – Frontiers in Neurology PMID: 25506338.

2014 – Aluminum and Glyphosate Can Synergistically Induce Pineal Gland Pathology: Connection to Gut Dysbiosis and Neurological Disease – Stephanie Seneff, Nancy Swanson, Chen Li – Agricultural Sciences, 2015, 6, 42-70.

2013 – Slow CCL2-dependent translocation of biopersistent particles from muscle to brain (Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P, Tillement O, Gherardi RK, Cadusseau J.- France – BMC Med).

2013 – Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep (Lluís Luján, Marta Pérez, Eider Salazar, Neila Álvarez, Marina Gimeno, Pedro Pinczowski, Silvia Irusta, Jesús Santamaría, et al – Espagne – Immunologic Research).

2013 – Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity (Shaw CA, Tomljenovic L – Canada – Immunol Res).

2013 – Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes (Shaw CA, Li Y, Tomljenovic L – Canada – Journal of Inorganic Biochemistry).

2013 – Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: An exploratory study (Nilusha Ragunathan-Thangarajah, Christine Le Beller, Pierre Boutouyrie, Guillaume Bassez, Romain K. Gherardi, Stéphane Laurent, François-Jérôme Authier – France – Journal of Inorganic Biochemistry).

2013 – Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice – G Pineton de Chambrun,MBody-Malapel, I Frey-Wagner, MDjouina, F Deknuydt, K Atrott, N Esquerre3, F Altare, C Neut, MC Arrieta, T-D Kanneganti, G Rogler, J-F Colombel, A Cortot, P Desreumaux and C Vignal – MucosalImmunology – published online 16 October 2013. doi:10.1038/mi.2013.78 – PMID : 24129165.

2013 – Aluminum’s Role in CNS-immune System Interactions leading to Neurological Disorders – Shaw CA, Kette SD, Davidson RM and Seneff S – Immunome Res 9: 069. doi: 10.4172/1745-7580.1000069.

2013 – Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects – Carlo Perricone, Serena Colafrancesco, Roei D. Mazor, Alessandra Soriano, Nancy Agmon-Levin, Yehuda Shoenfeld – Journal of Autoimmunity (2013), http://dx.doi.org/10.1016/j.jaut.2013.10.004.

2012 – Macrophagic myofasciitis: characterization and pathophysiology (RK Gherardi and FJ Authier – France – Lupus). Traduction française E3M.

2012 – Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations (Tomljenovic L, Shaw CA – Canada – Lupus).

2012 – Hepatitis B vaccine induces apoptotic death in Hepa1–6 cells (Heyam Hamza, Jianhua Cao, Xinyun Li, Changchun Li, Mengjin Zhu, Shuhong Zhao – Chine – Apoptosis).

2012 – Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure (Stephanie Seneff, Robert M. Davidson,  and Jingjing Liu – USA – Entropy).

2011 – Aluminum Vaccine Adjuvants: Are they Safe? (L. Tomljenovic et C.A. Shaw – Canada – Current Medicinal Chemistry). Traduction française E3M.

2011 – Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? – L. Tomljenovic, C. Shaw – Journal of Inorganic Biochemistry.

De 1998 à 2010

2010 – The immunobiology of aluminium adjuvants: how do they really work? (C. Exley, P. Siesjo et H. Eriksson – Grande-Bretagne – Trends in Immunology). Traduction française E3M.

2010 – Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months (J.Dórea JG, Marques RC.- Brésil – Expo Sci Environ Epidemiol).

2010 – « ASIA » – Syndrome auto-immunitaire/inflammatoire induit par les adjuvants (Y. Shoenfeld et N. Agmon-Levin – Israël – Journal of Autoimmunity). Traduction française E3M.

2009 – Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction (M. Couette, M.F. Boisse, P. Maison, P. Brugieres, P. Cesaro, X. Chevalier, R. K. Gherardi, A-C. Bachoud-Levi et F-J. Authier – France – Journal of Inorganic Biochemistry). Traduction française E3M.

2009 – Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration (C. A. Shaw et M.S. Petrik – Canada – Journal of Inorganic Biochemistry). Traduction française E3M.

2008 – A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome (C. Exley, L. Swarbrick, R. K. Gherardi et F-J. Authier – Grande-Bretagne, France – Elsevier, Medical Hypotheses). Traduction française E3M.

2001 – Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle (R. K. Gherardi, M. Coquet, P. Chérin, L. Belec, P. Moretto, P-A. Dreyfus, J-F. Pellissier, P. Chariot et F-J. Authier – Brain). Traduction française E3M.

1998 – Macrophagic myofasciitis: an emerging entity (Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L, Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M. – Lancet).